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Abstract
The present study assessed whether psychopathology influences obese 
subject’s ability to lose weight. The Minnesota Multiphasic Personality 
Inventory (MMPI) was used to differentiate between 46 pathological and 52 
nonpathological subjects. A repeated measures analysis of variance did 
not support the hypothesis that the degree of weight loss is negatively 
associated with the amount of psychopathology measured by the MMPI. In 
addition, an analysis of covariance was conducted in an attempt to 
control for possible confounding factors at the start of treatment and 
also failed to support the hypothesis.
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1Introduction
The purpose of this study is to determine whether psychopathology 
affects the amount of weight loss for obese individuals participating 
in an organized weight loss program. In a recent literature review, 
Wadden and Stunkard (1987) suggest that individual psychopathology is no 
greater in an obese population than a normal one. However, Ellsworth, 
Strain and Valliant (1986), Sanso (1984), Rabkin (1983), and Jonsson, 
Bjornwell, Lavander and Rosaner (1986), propose that psychopathology is a 
major predictive factor in obesity treatment outcome. In addition, 
clinical observation by obesity program staff (T. Korn, Personal 
communication, December 18, 1988) suggests that several distinct
personality styles occur among obese women which influence patient weight 
loss.
Two studies dealing with obesity have been conducted which suggest 
that personality styles may have predictive validity for treatment 
outcome. In one study (Scott & Baroffio (1986) assessed Minnesota 
Multiphasic Personality Inventory (MMPI) profiles of 30 hospitalized 
female anorexic patients, 30 hospitalized bulimic patients, 30 female 
morbidly obese patients (22-59 years of age), and 30 females in a control 
group and compared similarities and differences. The results indicated 
no significant difference in the overall profiles of the three 
experimental groups, but all differed from the control group. 
Specifically, obese participant’s MMPI scores represented more pathology 
than profiles of the normal-weighted control group. Another study 
assessed the relationship between personality factors and the loss of 
weight in 207 overweight subjects (Sanso, 1984). The MMPI was one of the 
tests used to measure personality factors. All subjects were given a diet
2of 700-1200 calories a day for eight weeks. The results suggested that 
personality variables have predictive value for treatment of obesity.
A contrasting point of view to the above is offered by Wadden and 
Stunkard (1987) who state that "The long-standing belief that obese 
persons suffer disproportionately from severe emotional disturbances 
appears to be incorrect” (p. 55). Studies by Hallstrom and Noppa (1981) 
and Larson (1978) ’’have supported the conclusion that emotional 
disturbance is no more common among the obese than among normal-weighted 
persons.” (Wadden and Stunkard, 1987, p. 55). The orientation of these 
researchers would suggest that use of psychopathology or type of 
psychopathology would be an ineffective way of predicting weight loss in 
an obesity program.
Clinical experience by treatment program staff in a large midwestern 
psychiatric hospital (T. Korn, Personal communication, December 18, 1988) 
suggests that patient psychopathology is a major issue related to the 
success or failure of participants undergoing obesity treatment. 
Specifically, hysterics, psychopathic deviants and depressives are the 
personality styles Korn (Personal communication, December 18, 1988)
believes influence weight loss. When related to the MMPI, it was 
predicted that scales 2,3 and 4 would be the most frequent pathologies 
encountered in the present study.
Subjects with elevated 3 and 4 MMPI scales score strongly in the 
hysteria and psychopathic deviant areas. These subjects typically are 
naive and insightless people (Carson, 1969). They tend to be very 
impulsive and strive for immediate gratification of their impulses. They 
often disregard the consequences of their actions and tend not to benefit 
from past experiences and consequently, many times find themselves
3confronted with the same difficulties repeatedly (Carson, 1969). Mello 
and Guthrie (1958) state that these individuals present problems rooted 
in an unhappy home situation, have difficulty with authority figures and 
worry about lack of acceptance by their social group. A large sex 
difference exists in respect to frequency of scale 3 peaks. For women, 
scale elevations are common, but for men such peaks are unusual 
(Dahlstrom, Welsh & Dahlstrom, 1972). Women with an elevated scale 3 (T 
score of 70 or above) tend to have an underlying sensuality and sexuality 
(Duckworth & Duckworth, 1975). Duckworth & Duckworth (1975) stated ’’Scale 
3 is more typically elevated on women’s profiles than it is on men’s." 
(p. 72).
Subjects with an elevated MMPI scale 2 often display depressive 
symptoms characterized by self-depreciation and guilt feelings. Duckworth 
& Duckworth (1975) proposes that individuals with a scale 2 elevated 
above 70 are usually experiencing "a long term unhappy situation with 
which the person has learned to live”. Gravitz (1968) reports that women 
who have an elevated 2 scale tend to report depression significantly more 
often (2 to 1) than men who have an elevated scale 2.
Duckworth and Duckworth (1975) defined the following MMPI scales 
when elevated to a T score of 70 or above. Scale 1 measures 
hypochondriasis and these individuals tend to use bodily complaints to 
avoid emotional issues and also tend to use these complaints as a way of 
manipulating others. Paranoid personality styles are represented by scale 
6 and these people tend to be suspicious and may assume other people are 
"after them". Righteous indignation is also usually present. 
Psychasthenia is assessed by scale 7 and measures anxiety. These 
individuals tend to be worried, tense and indecisive. Scale 8 measures
if
mental confusion. Difficulties in logical thinking may develop and these 
individuals may feel alienated from their social environment. Psychic 
energy is measured by scale 9 and is labeled hypomania. People scoring 
high on this scale seem to have an excess of energy and frequently take 
on more projects than they can complete. Much fantasy is usually present.
Scale 0 measures introversion and was not used in the present study as it
represents only mild pathological characteristics. Scale 5 attempts to 
determine whether one is more or less masculine or feminine. A T score 
above 70 on the aforementioned scale represents an individual who is 
uninterested in aesthetics and being female. Due to the fact that scale 5 
is not an appropriate measure of pathology, it was not considered in the 
present thesis. Due to their dysfunctional nature, individuals with a 
high degree of psychopathology participating in a weight loss program 
would be expected to benefit less than individuals with better mental
health. Regardless of whether emotional disturbances are just as common
among the obese as in normal-weighted individuals, the present study 
proposes that psychopathology has predictive value concerning the degree 
of weight loss in obesity therapy.
The Optifast program is a nationally standardized approach for the 
treatment of obesity. Optifast consists of four distinct stages and for 
the purposes of the present study are considered the treatment. The 
first phase (1) of the treatment program involves a 12-week fast during 
which the participants are exposed to intensive cognitive-behavioral, 
self-management training and an emphasis on graded exercise. The goals of 
Phase 1 are to facilitate maximal participant weight loss in as brief as 
possible time period that is medically safe, and at the same time to 
develop participant behavioral self-management skills appropriate to
5their "weight” problems. Supplementary nutritional education is conducted 
concurrently. All educational and training experiences are conducted in
the context of behaviorally based support groups. The only nourishment
participants receive during Phase 1 of the treatment program is a 
nutritionally balanced liquid dietary supplement of 420 or 800 calories 
per day. Participant daily caloric intake is determined by the exertional 
requirements of their occupation and their health status.
The second phase (2) of the treatment program involves graded 
re-feeding by the participant, in the context of continued 
self-management training, group support, and nutritional education. This 
phase lasts six weeks. The goal of the second phase is to reintroduce 
participants to a progressively more complex diet containing
nutritionally balanced solid food. The upper end of the participant 
caloric intake during Phase 2 does not exceed 1200 calories daily; all 
prior group treatments are conducted concurrently throughout this phase.
The purpose of the final phases (3 and 4) of the Optifast treatment 
program are weight stabilization and maintenance of their attained body 
weight. The third phase of the program involves a six-week dietary and 
behavioral stabilization period during which the maximum daily caloric 
consumption by the participant stabilizes and group therapy is 
concurrent. The fourth and final phase of the treatment program involves 
a long-term weight maintenance support group; this phase may last
indefinitely and involves supplementary behavioral management and
nutritional education training when needed. Due to the time constraints
of the present study, the fourth phase will last 30 days.
All treatment program groups were conducted by behavioral
specialists (psychologist or staff who had completed all the academic
requirements necessary for a doctoral degree in psychology except the 
dissertation), and all training materials, objectives, and guidelines 
were standardized with a cognitive behavioral emphasis. Nutritional 
education sessions were conducted within the behavioral treatment groups 
by dieticians working with the behavioral specialists.
3tudies which support the credibility of the Optifast program 
include Wadden, Stunkard, Brownell and Day (1984) where seventeen obese 
women, averaging 87% overweight, were treated for six months with a 
program of very low calorie diet (400-500 cal.) and behavior modification 
designed specifically for weight loss maintenance. The subjects showed 
significant reductions in anxiety and depression, even while consuming a 
very low calorie diet. Subjects lost an average of 45 pounds and regained 
an average of only 4.6 pounds during a one-year follow-up. Other studies 
validating the effectiveness of the Optifast program are those by 
Lockwood and Amatruda (1984), Vertes (1984), Tuck, Sowers, Dornfield, 
Kledzik and Maxwell (1981), and Vertes and Hazelton (1979).
The principal research question the present study addressed is 
whether the degree of pathology among women measured by the MMPI is
related to the degree of weight loss using the Optifast program. To
address this question the following hypothesis will be tested: Is the
degree of weight loss among women in the Optifast program negatively 
associated with the degree of pathology measured by the MMPI?
Method
Design
The study was conducted utilizing a retrospective, 
quasi-experimental design as body weight data had already been collected
by Optifast program staff. Data for the study was obtained from the
participants in an Optifast program (currently residing in the Omaha 
area) who had consented and taken the MMPI as part of their preliminary 
assessment for participation in treatment.
Fig. 1 is presented in appendix A
Sub.iects
A sample of 171 female participants were taken from the Omaha 
Optifast clinic records. The subject’s MMPI scores were recorded and 
served to indicate pathology or nonpathology. The pathological and 
nonpathological groups were composed of 57 subjects each. Only the 147 
subjects who completed the treatment were used for analysis. Of the total 
number of subjects, 46 of the pathological subjects and 52 of the 
nonpathological participants completed the Optifast program. For actual 
inclusion in the study, all those participants that met the definition of 
the pathological group were included, whereas every other subject from 
the file pool was included in the nonpathological group. Subjects 
included in the pathological group scored at least two standard 
deviations above the mean on two or more of the eight MMPI scales which 
measure pathology. All subjects included in the nonpathological group 
obtained no MMPI scale elevation over a T score of 70, In reference to 
MMPI scale elevations reaching a T score of 70, Wadden and Stunkard 
(1985) stated, "scores of this magnitude, which are two standard 
deviations above the mean, are indicative of clinically significant 
psychopathology" (p. 1064). Figure 1 represents the frequency of the most 
elevated scale for each subject in the pathological group.
Dependent Variable
8The dependent variable in the present study was the subject’s body 
weight and was recorded during initiation of the program and at the end 
of each phase of the Optifast treatment. Participant’s body weight 
assessments were obtained from each patient’s case record.
Data Analysis
Analysis of MMPI personality styles in predicting weight loss was 
accomplished by using a mixed analysis of variance design (ANOVA). The 
design was a 2 (pathology) x 5 (phase) factoral design. A general linear 
models (GLM) framework was incorporated in the study because it 
efficiently analyzes unequal sample sizes (SAS User’s Guide, 1985).
An analysis of covariance (ANCOVA) was also used to test the 
principal hypothesis and thereby attempt to control for possible 
confounding factors at the start of treatment.
Results
The hypothesis tested whether those women who manifested the most 
psychopathology would not be as successful in losing weight as other 
females who appeared to have better mental health. As previously 
mentioned, a mixed design ANOVA was used to test this hypothesis.
The attrition rate was 19,3% for the pathological group and 8.8% for 
the nonpathological group. A chi-square was undertaken to assess the 
possibility of significant attrition rates between the groups and was 
nonsignificant {V = 5.99, df = 3, p = .11). Therefore, the results of
the present experiment do not appear to be confounded by significantly 
more subjects in the pathological group quitting the program when 
compared to individuals in the nonpathological group.
Qy
Fig. 2 is presented in appendix A
Figure 2 presents the mean body weight of each group at each phase. 
Inspection of figure 2 reveals initial differences between groups and 
remarkably parallel rates of weight loss for each group across the 5 
phases. Specifically the mean total weight loss at the end of treatment 
for the pathological group was 59.00 pounds and 55.04 pounds for the 
nonpathological group.
Table 1 is presented in appendix A
Table 2 shows the overall F values for the 2 x 5  mixed design ANOVA 
performed on the data. The pathological group differed in body weight 
throughout the entire treatment when compared to the nonpathological 
group (F = 9.07, df = 1/98, p < .01). The Optifast program produced a
significant weight loss for both groups across the five phases of
treatment as each lost similar amounts of weight during the program. (F = 
938.51, df = 4/98, p < .01). The analysis did not indicate a group by
phase interaction (F = 1.57, df = 4/98, p = .18). The lack of interaction
indicates the degree of weight loss is not negatively associated with the
degree of pathology measured by the MMPI. The primary hypothesis of the 
current thesis could not, therefore, be supported.
While the primary hypothesis was not supported by the ANOVA, 
inspection of Figure 2 revealed a rather large difference of 24.6 pounds 
between the initial weight levels of the pathological and nonpathological 
groups. Since the weight differences between groups may have confounded
10
any differential weight loss between them by a scale restriction, an 
ANCOVA was performed with the initial phase weights serving as the 
covariate. The ANCOVA indicated no significant main effect for group (F = 
.04, df = 1/98, p = .84) or phase (F = 1.17, df = 3/98, p = .32). When 
the initial phase weight difference is partialed out of the analysis, the 
pathological group’s body weight is not significantly different from the 
nonpathological group. The absence of a significant group by phase 
interaction (F = 1.56, df = 3/98, p = .20) suggests that the extent of
pathology is not an important consideration in determining weight loss in 
the Optifast program.
Discussion
The results of the ANOVA seem to support the effectiveness of the
Optifast program in that a main effect for phase was found to be
significant at the p < .01 level. These findings are in agreement with 
previous studies by Wadden, Stunkard, Brownell and Day (1984), Vertes
(1984), Tuck, Sowers, Dornfield, Kledzik and Maxwell (1981), and Vertes 
and Hazelton (1979) where the effectiveness of the Optifast program was 
validated. The Wadden, Stunkard, Brownell and Day (1984) study reported 
during a six month treatment period their subjects lost an average of 45 
pounds which compares favorably with the 57-pound mean weight loss found 
in the current study. Of the 147 subjects who completed the treatment, 
the Optifast program appears to be an effective means of weight loss.
The treatment seemed to be equally effective for both groups in the 
current study, regardless of the degree of pathology. One possible 
explanation for this uniform range of effectiveness may be the
multifaceted approach the program uses and is consistent with the results 
of Mordes and Rossini (Kozak, 1982) who summarized their approach to
11
obesity treatment as incorporating behavior modification, a hypocaloric 
diet, and graded exercise. These features are all included in the 
Optifast program. The majority of the subjects participating in the 
treatment seemed to identify and incorporate at least part of the 
program. Subjects with varying degrees of pathology may benefit from 
different parts of the program, but with the final outcome being nearly 
the same for each group in the present study.
The lack of relationship between personality variables and
participant weight loss found in the present thesis contrasts with 
Sanso’s (1984) finding that pathology has predictive value for obesity 
treatment success. The aforementioned discrepancy may be related to 
differences in sample size. Although the sample size of 98 subjects in 
the present study seems adequate to assess the hypothesis, Sanso (1984) 
used 207 subjects which may have made his study more sensitive.
The sensitivity of the present thesis as a test of the principal 
hypothesis could be improved in the future if additional data were 
collected on each subject. For example, weight as well as frame size 
could be used to calculate an ideal body weight for each participant. 
Therefore a percentage overweight figure could be calculated for each 
patient and such a measure might have unconfounded the initial weight 
differences observed between the two groups used in the present study. 
Perhaps such a statistic would unconfound the initial weight difference 
between the pathological and nonpathological groups.
Attrition rates were not found to be significantly disproportionate 
between groups. Degree of pathology did not seem to influence subject’s 
ability to complete the treatment. However, still more subjects in the 
pathological group dropped out of the treatment than from the
12
nonpathological group, as was hypothesized, but not to such a degree as 
to confound the test of the principal hypothesis.
The pathological group weighed significantly more than the 
nonpathological group at the initial phase of the program (F = 9.21, df = 
1/98, p <.01). The aforementioned findings seemed to offer indirect 
support for the principal hypothesis in that people with more pathology 
appear to be more obese than nonpathological individuals. Whether 
pathology causes obesity or obesity causes pathology is a question 
involving cause and effect which the present thesis did not assess. 
Future research should investigate why the pathological group was heavier 
than the nonpathological group at the start of the experiment. However, 
pathology does not appear to significantly influence weight loss.
A one year follow-up would be the next logical step in investigating 
any relationship between psychopathology and weight loss success. While 
the present study found no evidence of pathology influencing weight loss 
during treatment, it may be a significant factor in individuals 
maintaining their weight loss after exposure to the program. Additional 
research should focus on answering the preceding questions.
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Table I 
Analyses of Variance
d f  SS MS F
GROUP 1 55007.19 55007.19 9 .07
PHASE 4 221538.11 55384.52 938.51
GROUP
BY
PHASE
4 370.70 9 2 .6 8 1.57
ERROR
BETWEEN
96 582360.91 6 0 6 6 .2 6
ERROR
WITHIN 384 22661 .03 59.01
